1. Zouboulis. Dermatology 1998:196; 9-15.
   
   
2. Kligman AM. Post adolecent acne in females. Cutis 1991;48:75-77.
   
   
3. Garrie SA, Garrie EV. Anxiety and skin diseases. Cutis 1978;22:205-208.
   
   
4. Van der Meeren HLM, Van der Schaar WW, Van der Hurk CMAM. The psychological impact of severe acne. Cutis 1985;784-786.
   
   
5. Shuster S, Fisher GH, Harris E, Binnell D. The effect of skin disease on self image. Br J Dermatol 1978;99 (suppl 16):18-19.
   
   
6. Wu SF, Kinder BN, Trunnell TN, Fulton JE. Role of anxiety and anger in acne patients: a relationship with the severity of the disorder. J Am Acad Dermatol 1988;18:325-332.
   
   
7. Cunliffe WJ, Hull SM, Hughes BR. The Benefit of isotretinoin in the severely depressed/dysmorphophobic patient. Second International Congress on Psychiatry and Dermatology, University of Leeds (abstract), 1989
   
   
8. Koo JYM. The psychosocial impact of acne: patients perceptions. J Am Acad Dermatol 1995;32: S26-S30.
   
   
9. Koo JYM. Smith LL. Report on teenage acne and self esteem. National Family Opinion, Inc. Reported to American Medical Association, 1994.
   
   
10. Koo JYM. Smith LL. Psychological aspects of acne. Pediatric Dermatol 1991;8:185-187.
    
    
11. Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol 1987;17:25-32.
    
    
12. Shalita AR. Treatment of refractory acne. Dermatology 1980;3:23-24.
    
    
13. Griesemer RD. Emotionally triggered disease in a dermatologic practice. Psychiatr Ann 1978;407-412.
    
    
14. Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol 1989;14:194-198.
    
    
15. Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol 1989;14:194-198.
    
    
16. Jowett S, Ryan T. Skin disease and handicap: an analysis of skin conditions. Soc Sci Med 1985;20:425-429.
    
    
17. Cunliffe WJ. Acne and unemployment. Br J Dermatol 1986;115: 379-383.
    
    
18. Phillips KA. Body dysmorphic disorder, the distress of imagined ugliness. Am J Psychiatry 1991; 148:1138-1149.
    
    
19. Voorhees JJ, Wilkins JW Jr, Hayes E. Harrel ER. Nodulocystic acne as a phenotypic feature of the XYY genotype: report of five cases, review of all known XYY subjects whit severe acne, and discussion of XYY cytodiagnosis. Arch Dermatol 1972;105:913-919.
    
    
20. Damon A. Constitutional factors in acne vulgaris. Arch Dermatol 1957;76:172-178.
    
    
21. Hinrichsen J, Ivy AC. Incidence in the Chicago region of acne vulgaris. Arch Dermatol Syph 1938;975- 982.
    
    
22. Strauss JS, Pochi PE, Downing DT. Acne: perspectives. J Invest Dermatol 1974;62:321-325.
    
    
23. Morello AM, Downing DT, Strauss JS. Octadecadienoic acids in the skin surface lipids of acne patients and normal subjects. J Invest Dermatol 1976;66:319-323.
    
    
24. Downing DT, Stewart ME, Wertz PW, Strauss JS. Essential fatty acids and acne. J Am Acad Dermatol 1986;14:221-225. 25.
    
    
25. Melnik B, Plewig G. Neue lipidbiochemische Aspekte in der Pathogenese der follikûlaren Verhornungsstôrung bei Acne vulgaris. Z. Hautkr 1988;63:591-596.
    
    
26. McGinley KJ, Webster GF, Ruggieri MR, Leyden JJ. Regional variations in density of cutaneous propionibacteria: correlation of Propionibacterium acnes populations with sebaceous secretion. J Clin Microbiol 1978;12:672-675.
    
    
27. Rebello T, Hawk JLM. Skin surface glycerol levels in acne vulgaris. J Invest Dermatol 1978;70:352-354.
    
    
28. Kligman AM, Wheatley VR, Mills OH Jr. Comedogenicity of human sebum. Arch Dermatol 1970;102: 267-275.
    
    
29. Motoyoshi K. Enhanced comedo formation in rabbit ear skin by squalene and oleic acid peroxides. Br J Dermatol 1983;109:191-198.
    
    
30. Saint-Leger D, Bague A, Cohen E, Chivot M. A possible role for squalene in the pathogenesis of acne. I. In Vitro study of squalene oxidation. Br J Dermatol 1986;114:535-542.
    
    
31. Hassing GS. Inhibition of Corynebacterium acnes lipase by tetracycline. J Invest Dermatol 1971;56: 189-192.
    
    
32. Leeming JP, Holland KT, Cunliffe WJ. The microbial ecology of pilocebaceous units from human skin. J Gen Microbiol 1984;130: 803-807.
    
    
33. Leeming JP, Holland KT, Cunliffe WJ, The microbial colonisation of inflamed acne vulgaris lesions. Br J Dermatol 1988;118:205-208.
    
    
34. Marples RR, Leyden JJ, Stewart RN, Mills OH Jr, Kligman AM. The skin microflora in acne vulgaris. J Invest Dermatol 1974;62: 37-41.
    
    
35. Marples RR, Kligman AM, Ecological effects of oral antibiotics on the microflora of human skin. Arch Dermatol 1971;103:148-153.
    
    
36. Cornelius CE, Ludwig GD, Red flourescence of comedones: production of porphyrins by Corynebacterium acnes. J Invest Dermatol 1967;49:368-370.
    
    
37. Sauermann G, Ebens B, Hoppe U. Analysis of facial comedos by porphyrin fluorescence and image analysis. J Toxicol Cutan & Ocular Toxicol 1989/90;9:369-385.
    
    
38. Leyden JJ, McGinley KJ, Mills OH Jr, Kligman AM. Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 1975;65:382-384.
    
    
39. Blaüer M, Vaalasti A. Pauli SL, Ylikomi T, Joensuu T. Tuohimaa P. Location of androgen receptor in human skin. J Invest Dermatol 1991;97:264-268.
    
    
40. Lucky AW. Endocrine aspects of acne. Pediatr Clin North Am 1983;30:495-499.
    
    
41. Thiboutot D, Harris G, Iles V, Cimis G, Gilliland K, Hagaris S. Activity of the type 1, 5 a-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol 1995;105:571-214.
    
    
42. Heydenreich G. Testosterone and anabolic steroids and acne fulminans. Arch Dermatol 1989;125: 571-572.
    
    
43. Mayerhausen W, Riebel B. Acne fulminans nach anabolikaeinnahme Z. Hautkr 1989;64:875-880.
    
    
44. Pye RJ, Meyrick G, Pye MJ, Burton JL. Effect of oral contraceptives on sebum excretion rate. Br Med J 1977;II:1581-1582.
    
    
45. Strauss IS, Kligman AM, The effect progesterone and progesterone-like compounds on the human sebaceous gland. J Invest Dermatol 1961;36 (46):309-319.
    
    
46. Miller JA, Wojnarowska FT, Dowd PM et al. Anti- androgen treatment in women with acne: a controlled trial. Br J Dermatol 1986; 114:705-716.
    
    
47. Sperling LC, Heimer WL II. Androgen biology as a basic for the diagnosis and treatment of androgenic disorders in women I. J Am Acad Dermatol 1993;28:669-683.
    
    
48. Sperling LC, Heimer WL II. Androgen biology as a basic for the diagnosis and treatment of androgenic disorders in women II. J Am Acad Dermatol 1993;28:901-916.
    
    
49. Lucky AW, McGuire J, Rosenfield RL, Lucky PA, Rich BH. Plasma androgens in women with acne. J Invest Dermatol 1983;81:70-74.
    
    
50. Darley CR, Moore JW, Besser GM et al. Androgen statusin women with late onset or persistent acne vulgaris. Clin Exp Dermatol 1984; 9:28-35.
    
    
51. Lawerence D, Shaw M, Katz M. Elevated free testosterone concentration in men and women with acne vulgaris. Clin Exp Dermatol 1986;11:263-273.
    
    
52. Held BL. Nader S, Rodríguez-Rigau LJ, Smith KD, Steinberger E. Acne and hyperandrogenism. J Am Acad Dermatol 1984;10: 223-226.
    
    
53. Walton S, Cunliffe WJ, Keczkes K, Early As, Garrigle HHG, Katz M, Reese RA. Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris. Br J Dermatol 1995;133:249-253.
    
    
54. Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome;clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol 1989;30:459-470.
    
    
55. Franks S. Polycystic ovary syndrome: a changing perspective. Clin Endocrinol 1989;31:87-120.
    
    
56. Zander J, Mickan H, Holzmann K, Lohe KJ. Androluteoma syndrome of pregnancy. Am J Obstet Gynecol 1978;130:170-177.
    
    
57. Derksen J, Nagesser SK, Meinders AE, Haak HR, Van de Velde JH. Identification of virilizing adrenal tumors in hirsute women. N Engl J Med 1994;331:968-973.
    
    
58. Rose LI, Newmark SR, Strauss JS, Pochi PE. Adrenocortical hydroxylase deficiencies in acne vulgaris. J Invest Dermatol 1976;66:324-326.
    
    
59. Pekkarinen A, Sonck CE. Adrenocortical reserves in acne vulgaris: the urinary excretion de 17-ketosteroids and total 17- hydroxycorticosteroids. Act Derm Venereol (Stockh) 1962;42:200-210.
    
    
60. Plewig G. Follicular keratinization. J Invet Dermatol 1974;62: 308-315.
    
    
61. Holmes RL, Williams M, Cunliffe WJ. Pilo-sebaceous duct obstruction and acne. Br J Dermatol 1972;87:327-332.
    
    
62. Knaggs HE, Hughes BR, Morris C, Wood EJ. Holland DB, Cunliffe WJ. Immunohistochemical study of desmosomes in acne vulgaris. Br J Dermatol 1994;130:731-737.
    
    
63. Strauss JS, Kligman AM. The pathologic dynamics of acne vulgaris. Arch Dermatol 1960;82:779-790.
    
    
64. Knutson DD. Ultrastructural observation in acne vulgaris: the normal sebaceous follicle and acne lesions. J Invest Dermatol 1974; 62:288-307.
    
    
65. Plewig G, Fulton JE, Kligman AM. Cellular dynamics of comedo formation in acne vulgaris. Arch Dermatol Forsch 1971;242:12-29.
    
    
66. Lavker RM, Leyden JJ, McGinley KJ. The relationship between bacteria and the abnormal follicular keratinization in acne vulgaris. J Invest Dermatol 1981;77:325-330.
    
    
67. Van Scott EJ, MacCardle RC. Keratinization of the duct of the sebaceous gland and growth cycle of the hair follicle in the histogenesis of acne in human skin. J Invest Dermatol 1956;27:405-429.
    
    
68. Webster GF. Inflammation in acne vulgaris. J Am Acad Dermatol 1995;33:247-253.
    
    
69. Ingham E, Gowland G, Ward RM, Holland Kt, Cunliffe WJ. Antibodies to P. acnes and P. acnes exocellular enzymes in the normal population at various ages and in patients with acne vulgaris. Br J Dermatol 1987;116:805-812.
    
    
70. Puhvel SM, Hoffman IK, Sternberg TH. Corynebacterium acnes: presence of complement fixing antibodies to Corynebacterium acnes in the sera of patients with acne vulgaris. Arch Dermatol 1966;93: 364-366.
    
    
71. Palatsi R. Delayed Hypersensitivity and febrille acne conglobata. Acta Derm Venerol (Stockh) 1977; 57:51-53.
    
    
72. Rajka G. Delayed reactivity to bacterial and viral extracts in different dermatoses. Acta Derm Venereol (Stockh) 1970;50:281-286.
    
    
73. Webster GF, Leyden JJ, Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes inflammation 1980;4:261-269.
    
    
74. Kabongo Muamba ML. Exoenzymes of Propionibacterium acnes. Can J Microbiol 1982;28:758-761.
    
    
75. Webster GR Tsai CC, Leyden JJ, Neutrophil Iyisosomal release in response to Propionibacterium acnes. J Invest Dermatol 1979;72: 209 (abstract).
    
    
76. WebsterGF, Leyden JJ, Norman ME, Nilsson UR. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes. and Propionibacterium granulosu. Infect Immun 1978;22: 523-529.
    
    
77. Webster GF McArthur WP. Activation of components of the alternative pathway of complement Propionibacterium acnes. cellwall carbohydrate. J Invest Dermatol 1982;79:137-140.
    
    
78. Tucker SB, Rogers RS III, Winkeimann RK, Privett OS, Jordon RE. Inflammation in acne vulgaris: leukocyte atraction and cytotoxicity by comedonal material. J Invest Dermatol 1980;74:21-25.
    
    
79. Darley CR, Currey HLF, Baker H. Acne fulminans with arthritis in identical twins treated with isotretinoin. J R Soc Med 1984;77: 328-330.
    
    
80. González T, Gantes M, Bustabad S, Díaz-Flores L. Acne fulminans associated with arthritis in monozygotic twins. J Rheumatol 1985;12:389-390.
    
    
81. Wong SS, Pritchard MH, Holt PJA. Familial acne fulminans. Clin Exp Dermatol 1992;17:351-353.
    
    
82. McAuley D, Miller RA. Acne fulminans associated with inflammatory bowel disease. Arch Dermatol 1985;121:91-93.
    
    
83. Palatsi R, Oikarinen A. Hormonal analysis and delayed hypersensitivity reactions in identical twins with severe acne. Acta Derm Venereol (Stockh) 1979;59:157-160.
    
    
84. Heydenreich G. Testosterone and anabolic steroids and acne fulminans. Arch Dermatol 1989;125: 571-572.
    
    
85. Hunter LY, Hensigger RN. Destructive arthritis associated with acne fulminans: a case report. Ann Rheum Dis 1980;39:403-405.
    
    
86. Reizis Z, Trattner A, Hodak E, David M, Sandband M. Acne fulminans with hepatosplenomegaly and erythema nodosum migrans. J Am Acad Dermatol 1991;24:886-888.
    
    
87. Kellett J, Beck MH, Chalmers RJG. Erythema nodosum and circulating immune complexes in acne fulminans after treatment with isotretinoin. Br Med J 1985;290:820.
    
    
88. Jemec GBE, Rasmussen I. Bone lesions of acne fulminans: case report and review of the literature. J Am Acad Dermatol 1989;20: 353-357.
    
    
89. Palatsi R. Delayed hypersensitivity and febrille acne conglobata. Acta Derm Venereol (Stockh) 1977;57:51-53.
    
    
90. Traupe H, Muhlendahl KE von, Bramswig J, Happle R. Acne of the fulminans type following testosterone therapy in three excessively tall boys. Arch Dermatol 1988;124: 414-417.
    
    
91. Driesch P von der, Schell H, Haneke E. Acne fulminans: Therapie mit 13-cis-Retinsaûre und Indometazin. Z Hautkr 1986;61:1145-1151.
    
    
92. Hartmann RR, Plewig G. Acne fulminans: tratamento de 11 pacientes con ácido 13-cis-retinoico. Ann Bras Dermatol 1983;58:3-10.
    
    
93. Blanc D, Zultak M, Wendling D, Lonchampt F. Eruptive pyogenic granulomas and acne fulminans in two siblings treated with isotretinoin: a possible common pathogenesis. Dermatologica 1988;177: 16-18.
    
    
94. Cavicchini S, Ranza R, Brezzi A, Bottoni A, Tosi R, Caputo R. Acne fulminans with sacroiliitis during isotretinoin therapy. Eur J Dermatol 1992;2:327-328.
    
    
95. Kierland RR. Unusual pyodermas (hidrosadenitis suppurativa;acne conglobata, dissecting cellulitis of the scalp). A review. Minn Med 1951;34:319-341.
    
    
96. Brunsting HA. Hidradenitis suppurativa and other variants of acne. Arch Dermatol Syph 1952;65: 303-315.
    
    
97. Leach RD, Eykyn I, Corrin B, Taylor EA. Anaerobic axillari abscess. Br Med J 1979;II:5-7.
    
    
98. Shelley WB, Cahn MM. The pathogenesis of hidradenitis suppurativa in man: experimental and histologic observations. Arch Dermatol 1955;72:562-565.
    
    
99. Conway H, Stark RB, Climo S. The surgical treatment of chronic hidradenitis suppurativa. Surg Gynecol Obstet 1952;95:455-464.
    
    
100. Morgan WP, Leicester G. The role of epilation and deodorants in hidradenitis suppurativa. Arch Dermatol 1982;118:101-102.
     
     
101. Jemec GBE. Body weight in hidradenitis suppurativa. In: Marks R, Plewig G, ed. Acne and related disorders. London: Dunitz, 1989; 375-376.
     
     
102. Breitkopf C. Bockhorts J, Lippold A, Ernst K, Hundeiker M. Pyodermia fistulans sinifica (Akne inversa) und Rauchgewohnheiten. Z Hautkr 1995;70:332-334.
     
     
103. O´Loughlin S, Woods R, Kirke PN, Shanahan F, Byrne A, Drury MI: Hidradenitis suppurativa: glucose tolerance; clinical, microbiologic; and immunologic features and HLA frequencies in 27 patients. Arch Dermatol 1988;124:1043-1046.
     
     
104. Ebling FJG. Hidradenitis suppurativa: an androgen dependent disorder. Br J Dermatol 1986;115: 259-262.
     
     
105. Dvorak VC, Root RK, MacGregor RR. Host-defense mechanisms in hidradenitis suppurativa. Arch Dermatol 1977;113:450-453.
     
     
106. Eberle F, Adler G, Roth SL. Pyodermia fistulans sinifica und kongenitaler Alpha –1-Antitrypsinmange. Hautarzt 1980;31:100-104.
     
     
107. Jemec GBE, The symptomatology of hidradenitis suppurativa in women. Br J Dermatol 1988;119:345-350.
     
     
108. Röder-Wehrmann O, Küster W, Plewig G. Acne inversa: Diagnose und Therapie. Hautarzt 1991;42:5-8.
     
     
109. Grösser A. Surgical treatment of chronic axillary and genitocrural acne conglobata by split- thickness skin grafting. J Dermatol Surg Oncol 1982;8:391-398.
     
     
110. Curry SS, Gaither DH, King LE Jr. Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp: a case report and review of secondary squamous cell carcinomas. J Am Acad Dermatol 1981;4: 673-678.
     
     
111. Plewing G. Die sogenannten rezidivierenden Schwei&-drüsenabszesse und ihre chirurgische Behandlung. In: Schweiberer L, ed. Chirurgische und plastisch- chirurgische Aspekte bei Infektionen und infizierten Defekten der Körperoberfläche, der Extremitäten und der Analregion München: Zuckschwerdt. Arch Dermatol Syph 1983;17-25.
     
     
112. Nobl G. Follikularproze B der Kopfhaut. Arch Dermatol Syph 1905;74:80.
     
     
113. Wöbling RH, Milbradt R. Akne conglobata et sinificasive pyodermia fistulans sinifica. Akt Dermatol 1985;11:198-199.
     
     
114. Duperrat B, Meunier P, Pringuet R. Acné conglobata fessiére. Discussion d´une amylose secondaire. Bull Soc Fr Dermatol Syph 1957; 64:264-266.
     
     
115. Moschella SL, Klein Mh, Miller RJ. Perifolliculitis capitis abscedens et suffodiens: report of a successful therapeutic scalping. Arch Dermatol 1967;96:195-197.
     
     
116. Mortimer PS, Dawber RPR, Gales MA, Moore RA. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 1986;115:263-268.
     
     
117. Sawers RS, Randall VA, Ebling FJG. Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetates) and oestrogen therapy. Br J Dermatol 1986;115:269-274.
     
     
118. Hughes LE, Harrison BJ, Mudge M. Surgical management of hidradenitis – principles and results. In: Marks R. Plewig G, ed. Acne and related disorders. London: Dunitz, 1989;367-370.
     
     
119. Lapins J, Marcusson JA, Emtestam L. Surgical treatment of chronic hidradenitis suppurative: CO2 laser stripping-secondary intention technique Br J Dermatol 1994;131:551-556.
     
     
120. Comacho-Martínez F, Winkelmann RK. Solid facial edema as a manifestation of acne. J Am Acad Dermatol 1990;22:129-130.
     
     
121. Tosti A, Guerra L, Bettoli V, Bonelli U. Solid facial edema as a complication of acne vulgaris in twins J Am Acad Dermatol 1987; 843-844.
     
     
122. Jungfer B, Jansen T, Przybilla B, Plewig G. Solid persistent facial edema of acne: successful treatment with isotretinoin and ketotifen. Dermatology 1993;187:34-37.
     
     
123. Mills OH Jr, Kligman AM. Acne mechanica. Arch Dermatol 1975; 11:481-483.
     
     
124. Brun P, Baran R. Une acné mécanique méconnue:la dermite du cou des violinistes. Ann Deramtol Venereol 1984;111:241-245.
     
     
125. Peachey RDG; Matthews CNA: Fiddeler´s neck. Br J Dermatol 1978;98:669-674.
     
     
126. Bedane C, Souyri N. Les acnés induites. Ann Dermatol Venerol 1990;117:53-58.
     
     
127. Greenberg RD. Acne vulgaris associated winoth antigonadotropic (danazol) therapy. Cutis 1979;24: 431-432.
     
     
128. Brunner MS, Riddell JM Jr, Best WR. Cutaneous side effects of ACTH, cortisone and pregnenolone therapy. J Invest Dermatol 1951;16:205-210.
     
     
129. Sullivan M, Zeligman I. Acneiform eruption due to corticotropin. Arch Dermatol 1956;73:133-141.

131. Bean SE Acneiform eruption from tetracycline. Br J Dermatol 1971; 85:385-386.
     
     
132. Weary PE, Russell CM, Butler HK, Hsu YT. Acneiform eruption resulting from antibiotic administration. Arch Dermatol 1969;100: 179-183.
     
     
133. Sherertz EF. Acneiform eruption due to “megadose” vitamins B6 and B12. Cutis 1991;48:119-120.
     
     
134. Dupré A, Albarel N, Bonafe JL, Christol B, Lassere J. Vitamin B-12 induced acnes. Cutis 1991;48:119-120.
     
     
135. Michel PJ. Un cas d´ acné important du visage consécutif a 1´administration de vitamine B-12. Bull Soc Fr Dermatol Syph 1968; 76:131-132.
     
     
136. Greenwood R, Fenwick PBC, Cunliffe WJ. Acne and antikonvulsants. Br Med J 1983;287:1669-1670.
     
     
137. Jenkins RD, Ratner AC. Diphenylhydantoin and acne N Engl J Med 1972;287:148.
     
     
138. Heng MCY. Lithium carbonate toxicity: acneform eruption and other manifestations. Arch J Dermatol 1982;118:246-248.
     
     
139. Kanzaki T. Acneiform eruption induced by lithium carbonate. J Dermatol 1991;18:481-483.
     
     
140. Betti R, Uziel L, Inselvini E, Valle C, Crosti C. Severe acne-like lesions in chronic amineptine overdose and Hodgkin´s lymphoma. J Dermatol Treat 1994;5:143-144.
     
     
141. Vexiau P, Gourmel B, Castot A et al. Severe acne due to chronic amineptine overdose. Arch Dermatol Res 1990;282:103-107.
     
     
142. Cohen LK, George W, Smith R. Isoniazid-induced acne and pellagra: occurrence in slow inactivators of isoniazid. Arch Deramtol 1974;109:377-38
     
     
143. Burkhart CG. Quinidine-induced acne. Arch Dermatol 1981;117: 603-604.
     
     
144. Schmoeckel C, Von Liebe V. Akneiformes Exanthem durch Azathioprin. Hautarzt 1983;34:413-415.
     
     
145. Bencini PL, Montagnino G; Crosti C, Sala F, De Vecchio A. Acne in a kidney transplant patient treated with cyclosporin A. Br J Dermatol 1986;114:396-397.
     
     
146. Lowe L, Herbert AA. Cystic and comedonal acne: a side effect of etretinate therapy. Int J Dermatol 1989;28:482.
     
     
147. Traupe H, Mühlendahl KE von, Brämswig J, Happle R. Acne of the fulminans type following testosterone therapy in three exessively tall boys. Arch Dermatol 1988;124: 414-417.
     
     
148. Mayerhausen W, Riebel B. Acne fulminans nach Anabolikaeinnahme. Z Hautkr 1989;64:875-880.
     
     
149. Monk B, Cunliffe WJ, Layton AM; Rhodes DJ. Acne induced by inhaled corticosteroids. Clin Exp Dermatol 1993;18:148-150.
     
     
150. Kaidbey KH; Kligman AM. The pathogenesis of topical steroid acne. J Invest Dermatol 1974;62:31-36.
     
     
151. Plewig G, Kligman AM. Induction of acne by topical steroids. Arch Dermatol Forsch 1973;247:29-52.
     
     
152. Mills OH Jr, Kligman AM. Tretinoin treatment of steroid acne. Arch Dermatol 1973;108 381-384.
     
     
153. Manok M. Zur Pathogenese der Bromakne. Dermatologica 1963; 127:375-380.
     
     
154. Soper LE, Vitez TS, Weinberg D. Metabolism of halogenated anesthetic agents as a possible cause of acneiform eruption. Anesth Analg 1973;52:125-127.
     
     
155. Harrell BL, Rudolph AH. Kelp diet: a cause of acneiform eruption. Arch Dermatol 1976;112:560.
     
     
156. Hitch JM, Greenburg BG. Adolescent acne and dietary iodine. Arch Dermatol 1961;84:898-911.
     
     
157. Adams RM. Occupational skin disease. New York: Grune & Stratton; 1983.
     
     
158. Maibach HI; Gellin GA. Occupational and inodustrial dermatology. Chicago: Year Book Medical Publishers, 1982.
     
     
159. Plewig G. Zur Kinetik der Comedonen-Bildung bei Chloracne (Halowaxacne). Arch Klin Exp Dermatol 1970;238:228-241.
     
     
160. Czernielewski A, Skwarczynska-banys E. Oral treatment of acne vulgaris and oil acne with tetracycline. Dermatologica 1982; 165:62-65.
     
     
161. Crow KD. Chloracne and its potential clinical implications. Clin Exp Dermatol 1981;6:243-257.
     
     
162. Herxheimer K. Über Chlorakne. Münch Med Wochenschr 1899; 46:278.
     
     
163. Taylor JS, Wuthrich RC; Lloyd KM, Poland A. Chloracne from manufacture of new herbicide. Arch Dermatol 1977;113:616-619.
     
     
164. Goldmann PJ. Schwerste akute Chloracne, eine Massenintoxikation durch 2,3,6,7-Tetrachlordibenzodioxin. Haautarzt 1973;24: 149-152.
     
     
165. Kuratsune M, Yoshimura T, Matsuzaka J, Yamaguchi A. Epidemiologic study on Yusho, a poisoning caused by ingestion of rice oil contaminated with a commercial brand of polychlorinated biphenyls. Environ Health Perspect 1972;1:119-128.
     
     
166. Caputo R, Monti M, Ermacora E et al. Cutaneous manifestations of tetrachlorobenzo-p-dioxin in children and adolecents: follow-up 10 years after the Seveso, Italy, accident. J Am Acad Dermatol 1988; 19:812-819.
     
     
167. Mills OH Jr, Kligman AM. Comedogenicity of sunscreens: experimental observations in rabbits. Arch Dermatol 1982;118:417-419.
     
     
168. Plewig G, Fulton JE, Kligman AM. Pomade acne. Arch Dermatol 1970;101:580-584.
     
     
169. Lamberg SI. The course of acne vulgaris in military personnel in Southeast Asia. Cutis 1971;7:655-660.
     
     
170. Tucker SB Ocupational tropical acne. Cutis 1983;31:79-81.
     
     
171. Sneddon J, Sneddon I. Acne excoriée: a protective device. Clin Exp Dermatol 1983;8:65-68.
     
     
172. Teichmann AT, Bosse K, Ahrens F. Acne excoriée und Artefakt. Über die Bedeutung der Selbstbeschädigung. Hautarzt 1974;25:494-497.
     
     
173. Aversa AJ, Nagy R. Localized comedones following radiation therapy. Cutis 1983;31:296-303.
     
     
174. Stein KM, Leyden JJ, Goldschmidt H. Localized acneiform eruption following cobalt irradiation. Br J Dermatol 1972;87:274-279.
     
     
175. Orlow SJ. Cutaneous findings in craniofacial malformation syndromes. Arch Dermatol 1992;128: 1379-1386.
     
     
176. Steffen C. The acneiform eruption of Apert´s syndrome is not acne vulgaris. Am J Dermatopathol 1984;6:213-220.
     
     
177. Parker TL. Roth JG, Esterly NB. Isotretinoin for acne in Apert syndrome. Pediatr Dermatol 1992;9: 298-300.
     
     
178. Jahangier ZN, Jacobs JW SAPHO síndrome: common denominator for various bone and skin diseases. Ned Tijdschr Geneeskd 1997; 141(16):764-769.
     
     
179. Seukeran DC, Cunliffe WJ The treatment of acne fulminans: a review of 25 cases. Br J dermatol 1999; 141(2):307-9.
     
     
180. Winchester R Psoriatic arthritis and the spectrum of syndromes related to the SAPHO (synovitis, acne, pudtulosis, hyperostosis, and osteitis) syndrome. Curr opin Rheumatol 1999;11(4):251-6.
     
     
181. Gmyrek R, Grosman ME, Rudin D, Scher R. SHAPO syndrome: report of three cases and review of the literature. Cutis 1999; 64(4): 253-8.
     
     
182. Eyrich GK, Harder C, Sailer HF, Langenegger T, Bruder E, Michel BA Prymary chronic osteomyelitis associated with synovitis, acne, pustulosis, hyperostosis and osteitis (SHAPO syndrome) J oral pathol med 1999;28 (10):456-64.
     
     
183. Hayem G, Bouchad – Chabot A, Benali K, Roux S, Palazzo E, Silbermann – Hoffman O, Kahn MF, Meyer O SAPHO syndrome: a long- term follow-up study of 120 cases. Semin Arthritis Rheum 1999; 29 (3):159-71.
     
     
184. Villaverde V et. al. Acute anterior uveitis in a patient with scariliitis and acne conglobata.Rheumatology (oxford)1999; 38 (8):797-8.
     
     
185. Yeon HB, Lindor NM, Seidman JG Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15 q. Am J Hum Genet 2000; 66(4):1443-8.
     
     
186. Eyrich GK et. al. Diffuse chronic sclerosing osteomyelitis and the synovitis, acne, pustulosis, hyperostosis, osteitis (SHAPO) syndrome in two sisters. Int J oral Maxilofac Surg 2000;29(1):49-53.
     
     
187. Schilling F, Kessler S SHAPO syndrome: clinico-rheumatologic and radiologic differentiation and classification of a patient sample of 86 cases. Z. Rheumatol 2000;59 (1);1 a 28.
     
     
188. Webster GF, Leyden JJ. Characterization of serum-independent poly-morphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Inflammation 1980;4:324-329.
     
     
189. Vowels BR, Yang S, Leyden JJ. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 1995;63:3158- 3165.
     
     
190. Webster GF, Leyden JJ, Mc Ginley KJ, McArthur WP. Suppression of polymorphonuclear leukocyte chemotactic factor production in propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline and erytromycin. Antimicrob Agents Chemother 1982;21:770-772.
     
     
191. Esterly NB, Koransky JS, Furey NL, Trevisan M. Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy. Arch Dermatol 1984;120:1308-1313.
     
     
192. Leyden JJ, McGinley KJ, Cavalieri S, Webster GF, Mills OH, Kligman AM. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983; 8:41-45
     
     
193. Eady EA, Jones CE, Tipper JL, Cove JH, Cunliffe WJ, Layton AM. Antibiotic resistant propionibacteria in acne: need for polices to modify antibiotic usage. BMJ 1993; 306:555-556.
     
     
194. Crawford WW, Crawford IP, Stoughton RB, Cornell RC. Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in C. acnes. J Invest Dermatol 1979;72: 187-190.
     
     
195. Coates P, Adams CA, Cunliffe WJ, Eady EA, Leyden JJ et al. Does oral isotretinoin prevet P. Acnes resistance? Dermatology 1997; 1995(suppl):4-9.
     
     
196. Eady EA, Bojar RA, Jones CE, Cove JH, Holland KT, Cunliffe WJ. The effects of acne treated with a combination of benzoyl peroxide and erythromycin in skin carriage of erythromycin resistant propionibacteria. Brit J Derm 1996;134: 107-113.
     
     
197. Biro DE, Shalita AR. Clinical aspects of tropical retinoids. Skin Pharmacol 1993;1:53-60.
     
     
198. Kligman AM, Fulton JE, Plewin G. Topical vitamin A acid in acne vulgaris. Arch Dermatol 1969;99: 469-476.
     
     
199. Leyden JJ, Shalita AR. Rational therapy of acne vulgaris: An update on topical treatment. J Am Acad Dermatol 1986;15:907-915.
     
     
200. Eady EA, Cove JH, Holland KT, Cunliffe WJ. Superior antibacterial action and reduced incidence of bacterial resistance in minocycline copared to tetracycline-treated acne patients. Br Dermatol 1990;122:233-244.
     
     
201. Plewig G, Kligman AM. Acne and Rosacea, ed 2. Berlin Springer, 1993:726.
     
     
202. Esterly NB, Furey NL, Flanagan LE. The effect of antimicrobial agents on chemotaxis. J Invest Dermatol 1978;70:51-55.
     
     
203. Dreno B. Action du Chlorhydrate de minocycline (Mynocine) sur le chimiotactisme des polynucléaires chez l’ acnéique. Nouv Dermatol 1991;10:757-760.
     
     
204. Esterly NB, Koransky JS, Furey NL, Maurizio T. Neutrophil chemotaxis in patients with acnereceiving oral tetracycline therapy. Arch Dermatol 1984;120:1308-1313.
     
     
205. Webster GF, McGinley KJ, Leyden JJ. Inhibition of lipase production in Propionibacterium acnes by subminimal inhibitory concentrationsof tetracycline and erytromycin. Br J Dermatol 1981;104:453-457.
     
     
206. Webstwer GF, Leyden JJ, McGinley KJ, McArthur WP. Suppression of polymorphonuclear leukocyte chemotactic factor productionin Propionibacterium acnes by subminimal inhibitory concentartions of tetracyclines and erythromycin. Antimicrob Agents Chemother 1982;21:770-772.
     
     
207. Lever L, Marks R. Courrente views on the aetiology, pathogenesis and treatament of acne vulgaris. Drugs 1990;39:681-692.
     
     
208. Blair C. Treatament of acne vulgaris with lymecycline. Practitioner 1968;200:278-282.
     
     
209. Cunliffe WJ, Grosshans E, Belaich S, Meynadier J, Thomas L. A comparison of the efficacy and safety of lymecycline and minocycline in patiets with moderately severe acne vulgaris. Br J Dermatol, in press
     
     
210. Biller JA, Flores A, Buie T, Mazpr S, Katz AJ. Tetracycline-induced esophagitis in adolecent pacients. J Pediatr 1992;120:144-145.
     
     
211. Channer KS, Hollanders D. Tetracycline-induced esophageal ulceration. Br Med J 1981;282:1359- 2360.
     
     
212. Tzianetas I, Habal F, Keystone JS. Short report: Severe Hiccups secondary to doxycycline-induced esophagitis during treatment of malaria. Am J Trop Med Hyg 1996;54:203-204.
     
     
213. Orr J, Pelel Y, Shahar A. Mediastinitis secondary to esophageal ulceration after doxycillin. Harefuah 1994;126(suppl 4):193-194,239.
     
     
214. Simpson MB, Pryzbylik J, Innis B, Denham MA. Hemolytic anemia after tetracycline therapy. N Engl J Med 1985;312:840-842.
     
     
215. Chatam WW, Ross DW. Leukemoid blood reaction to tetracycline. South Med J 1983;76:1195-1196.
     
     
216. Gough A, Chapman S, Wagstaff K, Emery P, Elias E. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. Br Med J 1996;312: 169-172.
     
     
217. Pierog SH, AL Salihi FL, Cinotti D. Pseudotumor cerebri –A complication of tetracycline treatment of acne. J Adolesc Health Care 1986;7:139-140.
     
     
218. Minutello JS, Dimayuga RG, Carter J. Pseudotumor cerebri, a rare adverse reaction to tetracycline therapy. J Periodontol 1988;59: 848-851.
     
     
219. Bargman H. Lack of cross-sensitivity between tetracycline, doxycycline, and minocycline with regard to fixed drug sensitivity to tetracycline (letter). J Am Acad Dermatol 1984;11:900-901.
     
     
220. Dodds PR, Chi TN: Balanitis as a fixed drug eruption to tetracycline. J Urol 1985;133:1044-1045.
     
     
221. Tham SN, Know YK: Cross-reactivity in fixed drug eruptions to tetracyclines. Arch Dermatol 1996; 132:1134-1135.
     
     
222. Trueb RM, Burg G: acutte generalized exanthematous pustulosis due to doxycycline. Dermatology 1993;186:75-78.
     
     
223. Davies MG, Kersey PJW: Acute hepatitis and exfoliative dermatitis associated with minocycline. Br Med J 1989;298:1523-1524.
     
     
224. Curley RK, Verbov JL. Stevens-Jhonsons syndrome due to tetracyclines – A case report (doxycycline) and a review of the literature. Clin Exp Dermatol 1987;12:124-125.
     
     
225. Inoue CN, Kondo Y, Suwabe N, Igarashi Y, Tada K. Minocycline-related lupus in childhood (letter). Eur J Paediatr 1994;153:540
     
     
226. Gordon PM, White MI, Herriot R, Martin JC, Reid DM. Miocycline-associated lupus erythematosus. Br J Dermatol 1995;132:120-121.
     
     
227. Okano M, Imai S. Anaphylactoid symptoms due to oral minocycline (letter). Acta Derm Venereol (Stockh) 1996;76:164.
     
     
228. Epstein JH, Seibert JS. Porphyria-like cutaneous changes induced by tetracycline hydrochloride photosensibilisation. Arch Dermatol 1976;112:661-666.
     
     
229. Council on drugs. Evaluation of a new antimicrobial agent: Doxycycline monohydrate and doxycycline hyclate (Vibramycine). JAMA 1969;209:549.
     
     
230. Edwards R. Doxycycline and photosensitivity (letter). NZ Med J 1987;100:640.
     
     
231. Frost P, Weinstein GD, Gomez EC. Phototoxic potential of minocycline and doxycycline. Arch Dermatol 1972;5:681.
     
     
232. Allen JC. Minocycline. Ann Intern Med 1976;85:482-487.
     
     
233. Layton AM, Cunliffe WJ. Phototoxic eruptions due to doxycycline- A dose-related phenomenon. Clin Exp Dermatol 1993;18:425-427.
     
     
234. Bleasel AF, McLeod JG, Brown ML. Anosmia after doxycycline use. Med J Aust 1990;152:440.
     
     
235. Mandell GL, Douglas RG, Bennet JE. Principles and Practice of Infectious Diseases, ed 3. Edinburgh, Churchill Livingstone, 1990.
     
     
236. Gorard DA. Late-onset drug fever associated with minocycline. Postgrad Med J 1990;66:404-405.
     
     
237. Thibault MJ, Billick RC, Srolovitz H. Minocycline-induced Sweet´s syndrome. J Am Acad dermatol 1992;27:801-804.
     
     
238. Mensing H, Kowalzick L. Acute febrile neutrophilic dermatosis (Sweet´s syndrome) caused by minocycline. Dermatologica 1991; 182:43-46.
     
     
239. Parneix-Spake A. Bastuji-Garin S, Lobut JB, Erner J, Guyet-Rousset P, Revuz J, Roujeau JC. Minocycline as possible cause of severe protracted hypersensitivity drug reaction. Arch Dermatol 1995;131: 490-491.
     
     
240. Ho D, Tashkin DP, Bain ME, Sharma O. Pulmonary infiltrates eosinophilia associated with tetracycline. Chest 1979;78:33-36.
     
     
241. Dussopt C, Mornex JF, Cordier JF, Brune J. Poumon éosinophile aigu apres prise de minocyclina. Rev Mal Respir 1994;11:67-70.
     
     
242. Harel L, Amir J, Livni E, Straussberg R, Varsano I. Serum-sickness-like reaction associated with minocycline therapy in adolecents. Ann Pharmacother 1996;30:481-483.
     
     
243. Butler JM, Marks R, Sutherland R. Cutaneous and cardiac valvular pigmentation with minocycline. Cline Exp Dermatol 1985;10: 432-437.
     
     
244. Leffell DJ. Minocycline hydrochloride hyperpigmentation complicating treatment of venous ectasia of the extremities. J Am Acad Dermatol 1991;24:501-502.
     
     
245. Odell EW, Hodgson RP, Haskell R. Oral presentation of minocycline-induced black bone disease. Oral Surg Oral Med Oral Phatol Oral Radiol Endod 1995;79:459-461.
     
     
246. Hunt MJ, Salisbury ELC, Grace J, Armati R: Black breast milk due to minocycline therapy. Br J Dermatol 1996;134:943-944.
     
     
247. Goulden V, Glass D, Cunliffe WJ. Safety of long-term high-dose minocycline in the treatment of acne. Br J Dermatol 1996;134:693-695.
     
     
248. Gantz NM, Zawacki JK, Dickerson WJ. Pseudomembranous colitis associated with erythromycin. Ann Intern Med 1979;91:866-867.
     
     
249. Hawksworth CRE. Acute pancreatitis associated with infusion of eryhtromicin lactobionate (letter). Br Med J 1989;298:190.
     
     
250. Diehl AM, Latham P, Boitnott JK, Mann J, Maddrey WC: Cholestatic hepatitis fromm erytromicin ethylsuccinate. Report of two cases. Am J Med 1984;76:931-934.
     
     
251. May EF, Calvert PC. Aggravation of mayasthenia gravis by erythroycin. Ann Neurol 1990;28:577-579.
     
     
252. Schweitzer VG, Olson NR. Ototoxic effect of erythromycin therapy. Arch Otolaryngol 1984;110:258-260.
     
     
253. Shalita AR, Cunningham WJ, Leyden JJ, Pochi PP, Strauss JS. Isotretinoin treatment of acne and related disordes: an update. J Am Acad Dermatol 1993;9:629-638.
     
     
254. Lehcher-Ceyrac D, Weber-Buisset MJ. Isotretinoin and acne in practice: a prospective analysis of 188 cases over 9 years. Dermatology 1993;186:123-128.
     
     
255. Shalita AR. Monocutaneous and systemic toxicity of retinoid: monitoring and management. Dermatologica 1987:175 (suppl1): 151-157.
     
     
256. Thiboutot D, Harris G, Iles V, cimis G, Gilliland K, Hagari S. Activity of the type 1, 5a-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol 1995;105(2):209-214.
     
     
257. Randall VA, Ebling FJ. Is the metabolism of testerone to 5a-dihydrostestosterone required for androgen action in the skin? Br J Dermatol 1982;107:47-53.
     
     
258. Pochi P. Hormonal therapy of acne. Dermatol Clin 1983;1:377.
     
     
259. Strauss J, Kligman A. effect of cyclic progestin-estrogen therapy on sebum and acne in women. JAMA 1964;190:815.
     
     
260. Speroff L, DeCherney A. evaluation of a new generation of oral contraceptives. Obstet Gynecol 1993;81:1034-1047.
     
     
261. Lewis M, Heinemann L, Spitzer W, MacRae K, Bruppacher R. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Contraception 1997;56:129-140.
     
     
262. Redmont GP, Olson WH, Lippman JS, Kafrissen ME, Jones TM, Jorizzo JL. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. Obstet Gynecol 1997;89:615-622.
     
     
263. Marynick SP, Chakmajian ZH, McCaffree DL, Herdon JH. Androgen exess in cystic acne. N Engl J Med 1983;308:981-986.
     
     
264. Lucky AW, Hormonal Correlates of acne and hirsutism. Am J Med 1995;98 (suppl 1A):89-1A-94S.
     
     
265. Faloia E, Filipponi S, Mancini V, Morosini P, DePierro R. Treatmen with a gonadotropin-releasing hormone agonist in acne or idiopathic hirsutism. J Endocrinol Invest 1993;16:675-677.
     
     
266. Goodfellow A, Alaghband-Zadeh J, Carter G, Cream J, Holland S, Scully J, Wise P. Oral spironolactone improves acne vulgaris and reduces sebum excretion. Br J Dermatol 1984;11:209-214.
     
     
267. Marcoux D, Thiboutot D. Hormonal therapy for acne. J Cutan Med Surg 1996;1(suppl2):52-56.
     
     
268. van Waygen R, van den Ende A. experience in the longterm treatmen of patients with hirsutism and/or acne with cyproterone acetate-containing preparations: efficacy, metabolic and endocrine effects. Exp Clin Endocrinol Diabetes 1995;103:241-251.
     
     
269. Cusan L, Dupont A, Belanger A, Tremblay R, Mahnes G, Labrie F. Treatmen of hirsutism with the pure antiandrogen flutamide. J Am Acad dermatol 1990;23:462-469.
     
     
270. Wysowski D, Freiman J, Tourtelot J, Horton M. Fatal and nonfatal hepatotoxixity associated with flutamide. Ann Intern Med 1993;118: 860-864.
     
     
271. Thiboutot D. An overview of acne and its treatment. Cutis 1996;57 (1S):8-12.
     
     
272. Thiboutot D, Gilliland K, Light J, Lookingbill D. Androgen metabolism in sebaceous glands from subjects with and without acne. Submitted.
     
     
273. MacFarlane JT, Davies D. infantile acne associated with transient increases in plasma concentrations of luteinising hormone, and testosterone. BMJ 1981;282:1275-1276
     
     
274. Cove JH, Eady A, Culiffe WJ. Skin Carriage of Antibiotic-resistant coagulase-negative staphylococci in untreated subjects. J Antimicrob Chemoter 1990;25:459-469.
     
     
275. Forssman T. Antibiotic resistance in acne patients under antibiotic treatmen in comparison to an untreated control group with retrospective assessment of therapy. Curr Probl Dermatol 1995;22:91-97.
     
     
276. Physian`s Desk Reference. Tetracycline. 1996;1367.
     
     
277. Burket JM, Storrs FJ. Nodulocystic infantile acne occurring in a kindred of steatocystoma. Arch Dermatol 1987;123:432-433.
     
     
278. Horne HL, Carmichael AJ. Juvenile Nodulocystic acne responding to systemic isotretinoin. Br J Dermatol 1997;136:796-797.
     
     
279. McGuire J, Lawson JP. Skeletal changes associated with chronic isotretinoin and etretinate administration. Dermatologica 1987; 175:169-181.
     
     
280. Margolis DJ; Attie M, Leyden JJ. Effects of isotretinoin on bone mineralization during routine therapy with isotretinoin for acne vulgaris. Arch Dermatol 1996;132: 769-774.
     
     
281. Chew EW, Bingham A, Burrows D. Incidence of acne vulgaris in patients with infantile acne. Clin Exp dermatol 1990;15:376-377.
     
     
282. Lucky AW, Biro FM, Huster GA, Morrison JA, Elder N. Acne vulgaris in early adolescent boys. Arch Dermatol 1991;127:210-216.
     
     
283. Lucky AW, Biro FM, Huster GA, Leach AD, Morrison JA, Ratterman J. Acne vulgaris in premenarchal girls. Arch Dermatol 1994; 130:308-314.
     
     
284. Lucky AW, Biro FM, Simbartl LA, Morrison JA, Sorg NW. Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study. J Pediatr 1997;130:30-39.
     
     
285. Coleman WP, Klein JA. Use of the tumescent technique for scalp sugery, dermabrasion, and soft tissue reconstruction. J Dermatol Surg Oncol 1992;18:130-135.
     
     
286. Tiekemeier G, Goldberg DJ. Skin resurfacing with the Erbium: YAG laser. Dermatol Surg 1997;23:685-687.
     
     
287. Kye, YC. Resurfacing of pitted facial scars with a pulsed Er: YAG laser. Dermatol Surg 1997;23:880-883.
     
     
288. DeVore DP, Hughes E, Scott JB. Effectivenness of injectable filler materials for smoothing wrinkle lines and depressed scars. Med Progr Technol 1994;20:243-250.

ROSÁCEA

1. Wilkin J. Rosacea. Pathophysiology and treatment . Arch Dermatol 1994;130:359-366.
   
   
2. Kaminer M, Gilchrest B. The many faces of acne. JAAD 1995;32 (5, pt 3) S 6-14.
   
   
3. Plewig G. Rosacea. In: Fitzpatrick TB, Ilsen AZ, Wolffk, Freedberg IM, Austen KF, editors. Dermatology in general medicine. New York: Mc Graw-Hill; 1999;785-794.
   
   
4. Utas S et al. Helicobacter pylori eradication treatment reduces the severity of rosacea. JAAD 1999;40 (3):433-435.
   
   
5. Bamford JTM. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol 1999;135 (6):659-663.
   
   
6. Leontiadis G. et al. Non – gastrointestinal tract associations of Helicobacter pylori infection. What is the evidence? Arch Dermatol 1999;159(9):925-940.
   
   
7. Weston WL, Morelli JG. Steroid Rosacea in prepubertal childen. Arch Pediatr Adolesc Med 2000; 154(1):62-64.
   
   
8. Kligman A. Ocular Rosacea. Current concepts. Arch Dermatol 1997;133(1):89-90.
   
   
9. Quarterman MJ. Ocular Rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol 1997; 133:49-54.
   
   
10. Webster GF. Acne vulgaris. State of the science. Arch Dermatol 1999;(9):135.
    
    
11. Dahl MV. Topical metronidazol maintains remissions of rosacea. Arch Dermatol 1998;134:679-683.
    
    
12. Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papular pustular rosacea. JAAD 1999; 40(6 Suppl):961–965.
    
    
13. Forstinger C. Treatment of rosacea like demodicidosis with oral ivermectin and topical permethrin cream. JAAD 1999;41(5. Suppl): 775-777.
    
    
14. Wilkin J. Use of topical pruducts for maintaing remission in rosacea. Arch Dermatol 1999;(1):135.